Skip to main content

Vera Therapeutics, Inc.

VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001831828

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vera Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
1 insider, $4.67M in total
Insiders trading
1
Net value
−$4.67M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vera Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vera Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Fordyce MarshallPRESIDENT AND CEO235,244Sep 17, 20268
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR80,754Sep 14, 20265
Boman Nancy LeeChief Regulatory Officer44,987Aug 5, 20261
Seidenberg Beth CDirector131,553May 26, 20261
Morrissey MichaelDirector–May 26, 20261
Enright Patrick GDirector5,882May 26, 20262
Meyers James RDirector–May 26, 20262
Morrison Scott WDirector–May 26, 20261
Cheng AndrewDirector–May 26, 20261
Oliger Christy J.Director–May 26, 20261
Hall KimballDirector–May 26, 20261
Wright-Mitchell JaneChief Legal Officer42,403Mar 25, 20261
Hite ChristopherDirector–Mar 9, 20261
Johnson David LeeChief Operating Officer45,727Feb 25, 20262
Turner William D.Chief Regulatory Officer45,313Feb 25, 20265
Grant SeanCHIEF FINANCIAL OFFICER114,181Feb 25, 20262
Brenner RobertChief Medical Officer50,947Feb 25, 20262
Skelton Laurence MatthewChief Commercial Officer64,218Feb 25, 20262
Carter Jason SChief Legal Officer49,136Nov 25, 20251
Katabi MahaDirector2,793,987IndirectMay 16, 20250
Commodore Capital LP10% Owner4,400,000IndirectJan 12, 20240
Curley JoanneChief Development Officer26,962Aug 23, 20230
Lin CeliaChief Medical Officer11,010Aug 23, 20230
Tammenoms Bakker Juliet10% Owner1,714,285IndirectFeb 8, 20230
Longitude Venture Partners IV, L.P.10% Owner1,714,285IndirectFeb 8, 20230
Longitude Capital Partners IV, LLC10% Owner1,714,285IndirectFeb 8, 20230
Longitude Prime Partners, LLC10% Owner1,714,285IndirectFeb 8, 20230
Longitude Prime Fund, L.P.10% Owner1,714,285IndirectFeb 8, 20230
Healy James10% Owner3,467,156Feb 8, 20230
Sofinnova Management X, L.P.10% Owner3,467,156Feb 8, 20230
Sofinnova Venture Partners X, L.P.10% Owner3,467,156Feb 8, 20230
Sofinnova Management X-A, L.L.C.10% Owner3,467,156Feb 8, 20230
TC Group, LLC10% Owner2,960,231IndirectAug 19, 20220
Carlyle Investment Management LLC10% Owner2,960,231IndirectAug 19, 20220
Abingworth LLP10% Owner2,960,231IndirectAug 19, 20220
Carlyle Group Inc.10% Owner2,960,231IndirectAug 19, 20220
Carlyle Holdings I GP Inc.10% Owner2,960,231IndirectAug 19, 20220
Carlyle Holdings I GP Sub L.L.C.10% Owner2,960,231IndirectAug 19, 20220
Carlyle Holdings I L.P.10% Owner2,960,231IndirectAug 19, 20220
CG Subsidiary Holdings L.L.C.10% Owner2,960,231IndirectAug 19, 20220
Abingworth Bioventures 8 LP10% Owner2,960,231IndirectAug 19, 20220
Carlyle Genesis UK LLC10% Owner2,960,231IndirectAug 19, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)4:28 PM ETSep 152 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−18.5K$37.00−$684.5K−7.3%235.2K after10b5-1
Sep 4, 2026 (view filing)4:15 PM ETSep 22 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−18.5K$35.12−$649.6K−7.3%235.2K after10b5-1
Aug 12, 2026 (view filing)6:42 PM ETJul 736 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−46.3K$42.30−$1.96M−16.4%235.2K afterAmended4 lots10b5-1
Aug 12, 2026 (view filing)6:41 PM ETJun 2350 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−18.5K$37.93−$701.8K−7.3%235.2K afterAmended2 lots10b5-1
Aug 12, 2026 (view filing)6:39 PM ETMay 1292 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−18.5K$36.74−$679.7K−7.3%235.2K afterAmended2 lots10b5-1
Apr 15, 2026 (view filing)Apr 141 dayFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−23.0K$44.05−$1.01M−8.9%235.2K after3 lots10b5-1
Feb 25, 2026 (view filing)Feb 232 daysSkelton Laurence MatthewChief Commercial OfficerSSaleClass A Common Stock−1.58K$41.98−$66.4K−2.4%64.2K after
Feb 25, 2026 (view filing)Feb 232 daysBrenner RobertChief Medical OfficerSSaleClass A Common Stock−2.15K$41.98−$90.3K−4.1%50.9K after
Feb 25, 2026 (view filing)Feb 232 daysGrant SeanCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−4.95K$41.98−$207.8K−4.2%114.2K after
Feb 25, 2026 (view filing)Feb 232 daysYoung Joseph RSVP, FINANCE, CHIEF ACCT OFFCRSSaleClass A Common Stock−3.12K$41.98−$130.9K−4.6%64.7K after
Feb 25, 2026 (view filing)Feb 232 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−16.9K$41.98−$710.5K−6.2%257.2K after
Feb 25, 2026 (view filing)Feb 232 daysTurner William D.Chief Regulatory OfficerSSaleClass A Common Stock−2.19K$41.98−$91.8K−4.6%45.3K after
Feb 25, 2026 (view filing)Feb 232 daysJohnson David LeeChief Operating OfficerSSaleClass A Common Stock−2.58K$41.98−$108.3K−5.3%45.7K after
Dec 17, 2025 (view filing)Dec 152 daysTurner William D.Chief Regulatory OfficerSSaleClass A Common Stock−10.0K$50.08−$500.8K−30.8%22.5K after10b5-1
Dec 15, 2025 (view filing)Dec 114 daysEnright Patrick GDirectorPPurchaseClass A Common Stock+5.88K$42.50+$250.0KNew position5.88K after
Dec 10, 2025 (view filing)Dec 82 daysTurner William D.Chief Regulatory OfficerSSaleClass A Common Stock−10.0K$45.31−$453.1K−30.8%22.5K after10b5-1
Dec 4, 2025 (view filing)Dec 31 dayTurner William D.Chief Regulatory OfficerSSaleClass A Common Stock−10.0K$40.00−$400.0K−30.8%22.5K after10b5-1
Nov 25, 2025 (view filing)Nov 214 daysCarter Jason SChief Legal OfficerSSaleClass A Common Stock−3.86K$27.82−$107.5K−7.3%49.1K after
Nov 13, 2025 (view filing)Nov 112 daysYoung Joseph RSVP, FINANCE, CHIEF ACCT OFFCRSSaleClass A Common Stock−15.0K$29.06−$435.9K−23.9%47.8K after
Jun 25, 2025 (view filing)Jun 23-242 daysEnright Patrick GDirectorPPurchaseClass A Common Stock+250.0K$21.11+$5.28M+7.5%3.60M after4 lots
Feb 27, 2025 (view filing)Feb 21-266 daysLateFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−19.7K$27.78−$546.9K−8.8%204.7K after3 lots10b5-1
Jan 10, 2025 (view filing)Jan 82 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−17.5K$41.74−$730.5K−10.9%143.6K after3 lots10b5-1
Dec 20, 2024 (view filing)Dec 182 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−17.5K$43.07−$753.7K−16.9%85.9K after5 lots10b5-1
Dec 13, 2024 (view filing)Dec 112 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−17.5K$46.94−$821.5K−16.9%85.9K after4 lots10b5-1
Nov 27, 2024 (view filing)Nov 252 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−19.4K$47.98−$929.5K−18.4%85.9K after5 lots10b5-1
Nov 15, 2024 (view filing)Nov 132 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−30.6K$49.50−$1.52M−26.3%85.9K after9 lots10b5-1
Oct 30, 2024 (view filing)Oct 282 daysSeidenberg Beth CDirectorSSaleClass A Common Stock−15.0K$48.03−$720.5K−10.2%131.6K after2 lots10b5-1
Oct 25, 2024 (view filing)Oct 232 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−19.4K$40.40−$782.7K−5.9%308.0K after4 lots10b5-1
Oct 11, 2024 (view filing)Oct 92 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−15.6K$38.24−$597.5K−4.8%308.0K after2 lots10b5-1
Sep 27, 2024 (view filing)Sep 252 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−23.1K$46.05−$1.06M−7.0%308.0K after11 lots10b5-1
Sep 20, 2024 (view filing)Sep 18-192 daysSeidenberg Beth CDirectorSSaleClass A Common Stock−15.0K$42.29−$634.3K−9.3%146.6K after2 lots10b5-1
Sep 20, 2024 (view filing)Sep 182 daysSeidenberg Beth CDirectorSSaleClass A Common Stock−1.48K$42.00−$62.0K−26.9%4.01K after10b5-1
Sep 13, 2024 (view filing)Sep 112 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−15.6K$37.50−$586.0K−4.8%308.0K after2 lots10b5-1
Aug 30, 2024 (view filing)Aug 282 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−30.3K$36.84−$1.12M−9.0%308.0K after4 lots10b5-1
Aug 23, 2024 (view filing)Aug 212 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−14.5K$39.76−$575.4K−4.3%322.7K after
Aug 16, 2024 (view filing)Aug 142 daysFordyce MarshallPRESIDENT AND CEOSSaleClass A Common Stock−15.6K$37.56−$586.9K−4.4%337.1K after10b5-1
May 17, 2024 (view filing)May 15-162 daysYoung Joseph RSVP, FINANCE, CHIEF ACCT OFFCRSSaleClass A Common Stock−30.8K$42.30−$1.30M−37.6%51.2K after4 lots
Apr 12, 2024 (view filing)Apr 102 daysYoung Joseph RSVP, FINANCE, CHIEF ACCT OFFCRSSaleClass A Common Stock−5.71K$40.00−$228.6K−9.7%53.2K after
Apr 5, 2024 (view filing)Apr 32 daysGrant SeanCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−99.8K$39.61−$3.95M−60.1%66.3K after4 lots
Apr 5, 2024 (view filing)Apr 32 daysGrant SeanCHIEF FINANCIAL OFFICERSSaleClass A Common Stock−18.6K$39.42−$735.2K−78.9%5.00K after15 lots
Mar 25, 2024 (view filing)Mar 21-254 daysKatabi MahaDirectorSSaleClass A Common Stock−834.5K$40.86−$34.1M−23.0%2.79M after6 lots
Feb 1, 2024 (view filing)Jan 302 daysKatabi MahaDirectorPPurchaseClass A Common Stock+161.3K$31.00+$5.00M+4.7%3.63M after
Jan 12, 2024 (view filing)Jan 102 daysCommodore Capital LP10% OwnerSSaleClass A Common Stock−1.05M$18.00−$18.9M−19.3%4.40M after
Aug 23, 2023 (view filing)Aug 212 daysLin CeliaChief Medical OfficerSSaleClass A Common Stock−1.49K$16.65−$24.8K−11.9%11.0K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysCurley JoanneChief Development OfficerSSaleClass A Common Stock−1.49K$16.66−$24.8K−5.2%27.0K after10b5-1
Aug 23, 2023 (view filing)Aug 212 daysFordyce MarshallPresident and CEOSSaleClass A Common Stock−5.21K$16.66−$86.8K−2.1%243.4K after10b5-1
Jun 23, 2023 (view filing)Jun 23Same dayGrant SeanChief Financial OfficerPPurchaseClass A Common Stock+5.00K$16.60+$83.0K+504.0%5.99K after
Jun 22, 2023 (view filing)Jun 202 daysCommodore Capital LP10% OwnerPPurchaseClass A Common Stock+448.2K$15.17+$6.80M+9.0%5.45M after
Apr 3, 2023 (view filing)Mar 304 daysSeidenberg Beth CDirectorPPurchaseClass A Common Stock+2.30K$7.24+$16.7K+0.1%1.95M after
Mar 30, 2023 (view filing)Mar 282 daysSeidenberg Beth CDirectorPPurchaseClass A Common Stock+23.9K$7.24+$173.1K+1.2%1.95M after